Epigenetics Meets Estrogen Receptor: Regulation of Estrogen Receptor by Direct Lysine Methylation

Overview

Journal Endocr Relat Cancer

Specialties Endocrinology
Oncology

Date 2009 Feb 12

PMID 19208734

Citations 11

Authors

Qun Zhou

Patrick G Shaw

Nancy E Davidson

Affiliations

Soon will be listed here.

Citing Articles

Insight into the Potential Mechanisms of Endocrine Disruption by Dietary Phytoestrogens in the Context of the Etiopathogenesis of Endometriosis.

Szukiewicz D Int J Mol Sci. 2023; 24(15).

PMID: 37569571 PMC: 10418522. DOI: 10.3390/ijms241512195.

Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action.

Jouffre B, Acramel A, Belnou M, Santolla M, Talia M, Lappano R Sci Rep. 2023; 13(1):1326.

PMID: 36693877 PMC: 9873809. DOI: 10.1038/s41598-023-28062-9.

Oncogene or Tumor Suppressor: The Coordinative Role of Lysine Methyltransferase SET7/9 in Cancer Development and the Related Mechanisms.

Gu Y, Zhang X, Yu W, Dong W J Cancer. 2022; 13(2):623-640.

PMID: 35069908 PMC: 8771520. DOI: 10.7150/jca.57663.

Estrogen- and Progesterone (P4)-Mediated Epigenetic Modifications of Endometrial Stromal Cells (EnSCs) and/or Mesenchymal Stem/Stromal Cells (MSCs) in the Etiopathogenesis of Endometriosis.

Szukiewicz D, Stangret A, Ruiz-Ruiz C, Olivares E, Soritau O, Susman S Stem Cell Rev Rep. 2021; 17(4):1174-1193.

PMID: 33411206 PMC: 8316205. DOI: 10.1007/s12015-020-10115-5.

Biological processes and signal transduction pathways regulated by the protein methyltransferase SETD7 and their significance in cancer.

Batista I, Helguero L Signal Transduct Target Ther. 2018; 3:19.

PMID: 30013796 PMC: 6043541. DOI: 10.1038/s41392-018-0017-6.

References

Fuqua S, Wiltschke C, Zhang Q, Borg A, Castles C, Friedrichs W . A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions. Cancer Res. 2000; 60(15):4026-9. View

Conway K, Parrish E, Edmiston S, Tolbert D, Tse C, Geradts J . The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study. Breast Cancer Res. 2005; 7(6):R871-80. PMC: 1410768. DOI: 10.1186/bcr1315. View

Rastelli F, Crispino S . Factors predictive of response to hormone therapy in breast cancer. Tumori. 2008; 94(3):370-83. DOI: 10.1177/030089160809400314. View

Kim M, Woo E, Chong Y, Homenko D, Kraus W . Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. Mol Endocrinol. 2006; 20(7):1479-93. PMC: 1483068. DOI: 10.1210/me.2005-0531. View

Subramanian K, Jia D, Kapoor-Vazirani P, Powell D, Collins R, Sharma D . Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase. Mol Cell. 2008; 30(3):336-47. PMC: 2567917. DOI: 10.1016/j.molcel.2008.03.022. View

Sims 3rd R, Nishioka K, Reinberg D . Histone lysine methylation: a signature for chromatin function. Trends Genet. 2003; 19(11):629-39. DOI: 10.1016/j.tig.2003.09.007. View

Sentis S, Le Romancer M, Bianchin C, Rostan M, Corbo L . Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity. Mol Endocrinol. 2005; 19(11):2671-84. DOI: 10.1210/me.2005-0042. View

Wang H, Cao R, Xia L, Erdjument-Bromage H, Borchers C, Tempst P . Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Mol Cell. 2002; 8(6):1207-17. DOI: 10.1016/s1097-2765(01)00405-1. View

Tokunaga E, Kimura Y, Maehara Y . No hypersensitive estrogen receptor-alpha mutation (K303R) in Japanese breast carcinomas. Breast Cancer Res Treat. 2004; 84(3):289-92. DOI: 10.1023/B:BREA.0000019963.67754.93. View

10.

Berry N, Fan M, Nephew K . Estrogen receptor-alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome. Mol Endocrinol. 2008; 22(7):1535-51. PMC: 2453605. DOI: 10.1210/me.2007-0449. View

11.

Ottaviano Y, Issa J, Parl F, Smith H, Baylin S, Davidson N . Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res. 1994; 54(10):2552-5. View

12.

Strahl B, Allis C . The language of covalent histone modifications. Nature. 2000; 403(6765):41-5. DOI: 10.1038/47412. View

13.

Yager J, Davidson N . Estrogen carcinogenesis in breast cancer. N Engl J Med. 2006; 354(3):270-82. DOI: 10.1056/NEJMra050776. View

14.

Huq M, Tsai N, Khan S, Wei L . Lysine trimethylation of retinoic acid receptor-alpha: a novel means to regulate receptor function. Mol Cell Proteomics. 2007; 6(4):677-88. DOI: 10.1074/mcp.M600223-MCP200. View

15.

Sharma D, Saxena N, Davidson N, Vertino P . Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. Cancer Res. 2006; 66(12):6370-8. PMC: 2925469. DOI: 10.1158/0008-5472.CAN-06-0402. View

16.

Macaluso M, Montanari M, Noto P, Gregorio V, Bronner C, Giordano A . Epigenetic modulation of estrogen receptor-alpha by pRb family proteins: a novel mechanism in breast cancer. Cancer Res. 2007; 67(16):7731-7. DOI: 10.1158/0008-5472.CAN-07-1476. View

17.

Pedram A, Razandi M, Wallace D, Levin E . Functional estrogen receptors in the mitochondria of breast cancer cells. Mol Biol Cell. 2006; 17(5):2125-37. PMC: 1446071. DOI: 10.1091/mbc.e05-11-1013. View

18.

Leader J, Wang C, Popov V, Fu M, Pestell R . Epigenetics and the estrogen receptor. Ann N Y Acad Sci. 2007; 1089:73-87. DOI: 10.1196/annals.1386.047. View

19.

Kouskouti A, Scheer E, Staub A, Tora L, Talianidis I . Gene-specific modulation of TAF10 function by SET9-mediated methylation. Mol Cell. 2004; 14(2):175-82. DOI: 10.1016/s1097-2765(04)00182-0. View

20.

Davies M, ONeill P, Innes H, Sibson D . Hypersensitive K303R oestrogen receptor-alpha variant not found in invasive carcinomas. Breast Cancer Res. 2005; 7(1):R113-8. PMC: 1064111. DOI: 10.1186/bcr965. View